<DOC>
	<DOCNO>NCT00161850</DOCNO>
	<brief_summary>The purpose study investigate safety immunogenicity third vaccination one three different concentration TBE vaccine subject complete two vaccination one three treatment group Baxter study 199 ( dose-finding study investigate safety immunogenicity two vaccination FSME IMMUN NEW healthy subject age 1 6 year ) .</brief_summary>
	<brief_title>FSME IMMUN NEW Follow-up Study 199 Children Aged 1 6 Years</brief_title>
	<detailed_description />
	<mesh_term>Encephalitis</mesh_term>
	<mesh_term>Encephalitis , Tick-Borne</mesh_term>
	<criteria>All volunteer participate Baxter study 199 receive two vaccination invited participate . Male female child eligible participation study : They receive two vaccination one three different dosage FSME IMMUN NEW course Baxter study 199 Written inform consent legal guardian available . There specific exclusion criterion study entry . However volunteer assess eligibility receive third vaccination . Volunteers exclude vaccination consecutive visit study : Are clinically healthy , ( i. e. physician would reservations vaccinate FSME IMMUN NEW outside scope clinical trial ) Have already administer third TBE vaccination elsewhere two vaccination Baxter study 199 Have allergic reaction one component vaccine since last vaccination Baxter study 199 Suffer disease ( e.g . autoimmune disease ) undergo form treatment ( e.g . systemic corticosteroid , chemotherapeutics ) expect influence immunological function Have receive banked human blood immunoglobulin within one month study entry Are know HIV positive ( special HIV test require purpose study ) since last visit Baxter study 199 Have vaccination yellow fever / Japanese Bencephalitis since last visit Baxter study 199 Had receive investigational new drug within 6 week prior study start</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>6 Years</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>